TrialScientific reports2024

Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS).

Snigdha Komakula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.